| Registry | NCT04574752 |
|---|---|
| Status | Unknown |
| Study type | Observational |
| Enrollment | 163 (Actual) |
| Sponsor | Rothman Institute Orthopaedics (Other) |
| Conditions | Staphylococcus Aureus, Next Generation Sequencing, Total Joint Arthroplasty |
| Interventions | next generation sequencing (Diagnostic test) |
| Dates | start 2020-08-30, primary completion 2021-08-30 (estimated), completion 2021-08-30 (estimated), first posted 2020-10-05, last updated 2020-10-05 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Staphylococcus Aureus All trials for Next Generation Sequencing All trials of next generation sequencing
The aims of this study were to evaluate the diagnostic performance of molecular and culture techniques in S. aureus screening using paired nasal and groin swabs, to determine, if any, discrepancy between the diagnostic techniques and to model the potential effect of different diagnostic techniques on S. aureus detection in orthopaedic patients
Sex: All, ages: 18 Years to 80 Years, accepts healthy volunteers
Inclusion Criteria: * All patients undergoing primary total knee or total hip arthroplasty at our institution will be eligible. Exclusion Criteria: * Patients included in other prospective studies
| Facility | City | Country | Status |
|---|---|---|---|
| Rothman Orthopaedic Institute | Philadelphia, Pennsylvania | United States |